Home Newsfeeds Baird Downgrades Myovant Sciences to Neutral, Raises Price Target to $27

Baird Downgrades Myovant Sciences to Neutral, Raises Price Target to $27

Baird analyst Brian Skorney downgrades Myovant Sciences (NYSE:MYOV) from Outperform to Neutral and raises the price target from $20 to $27.

byBenzinga Newsdesk

October 24, 2022

1 minute read

Baird analyst Brian Skorney downgrades Myovant Sciences (NYSE:MYOV) from Outperform to Neutral and raises the price target from $20 to $27.

Shiba Inu Spikes 516% In Daily Transactions, 220% For Whales: Trader Says ‘SHIB History Repeats Itself’

By Khyathi Dalal

March 26, 3:32 PM

‘Dogecoin Killer' Shiba Inu (CRYPTO: SHIB) is demonstrating resilience with a 1% gain amid a notable surge in its daily transactions and whale activities.

$SHIB

Analyst Ratings

What 9 Analyst Ratings Have To Say About Edison

By Benzinga Insights

November 2, 9:46 AM

Over the past 3 months, 9 analysts have published their opinion on Edison (NYSE:EIX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

EIX

House Leader, Taiwan President Hold Historic Meeting In U.S.

By Happy Mohamed

April 5, 1:31 PM

https://kion546.com/news/ap-california/2023/04/05/house-leader-taiwan-president-hold-historic-meeting-in-us/ House Speaker Kevin McCarthy welcomed Taiwan’s President Tsai Ing-wen for a historic meeting on U.S.

EWT